Columbia Financ SEC Filings

Kemly Thomas J., President & CEO and a director of Columbia Financial, Inc. (CLBK), reported transactions on 08/22/2025. The filing shows an acquisition coded A of 116.4254 units at a price of $15.35 under the Columbia Bank Stock Based Deferral Plan, which will be settled in shares on distribution. The report lists multiple categories of beneficial ownership including units held in a 401(k), ESOP, SERP, SIM, spouse, and several stock awards, totaling indictive owned amounts by category (for example 233,808 shares disposed, and indirect holdings such as 65,436.603 shares by the Stock-Based Deferral Plan). The filer also discloses outstanding stock options at various strike prices ($15.60, $15.94, $16.49, $16.23) with exercise/expiration schedules and sizeable option quantities (for example 656,471 options exercisable at $15.60).

Columbia Financial, Inc. (CLBK) Form 4 summary: On 08/22/2025 Allyson Katz Schlesinger, SEVP & Head of Consumer Banking and a director/officer, is reported as acquiring 21.7993 units under the Columbia Bank Stock Based Deferral Plan at a price of $15.35 per unit. The filing shows various categories of beneficial ownership across plans and awards, including indirect ownership of 13,346.307 shares via the Stock Based Deferral Plan and multiple other holdings reported as ESOP (6,683), SERP (6,459), SIM (4,683), and several stock awards and option pools.

The report also discloses outstanding company stock options exercisable into common stock (totaling 198,507 options across four grants) with exercise prices ranging from $15.60 to $16.49 and various vesting schedules. The form was signed by power of attorney on 08/26/2025.

Columbia Financial, Inc. (CLBK) Form 4 filed for Jenifer White, EVP & CHRO. The filing reports a non-derivative acquisition on 08/22/2025 of 34.7029 phantom stock units under the Columbia Bank Stock Based Deferral Plan at an attributable price of $15.35 per share equivalent, which will be settled in shares upon distribution. The report also discloses various existing direct and indirect holdings: 3,352 shares direct, and multiple indirect holdings through ESOP, SERP, SIM and four named stock awards totaling thousands of shares. Separately, the filing lists outstanding stock options exercisable for a combined 28,147 shares with exercise prices from $15.94 to $20.54 and expirations in 2032–2035.

John Klimowich, listed as SEVP & Chief Risk Officer, reported transactions on 08/22/2025 for Columbia Financial, Inc. (CLBK). The filing shows a purchase of 41.5935 phantom stock units at $15.35 under the Columbia Bank Stock Based Deferral Plan, which are to be settled in shares upon distribution. The report also discloses the reporting person’s beneficial holdings across multiple accounts and awards, including 60,769 shares held directly, and various indirect holdings and stock awards and options such as 188,235 underlying shares from vested options and additional option grants totaling 41,190 underlying shares across later grants. The Form 4 is signed by a power of attorney.

Torres Daria Stacy-Walls, a director of Columbia Financial, Inc. (CLBK), reported transactions dated 08/08/2025. The filing shows an acquisition of 644.9177 phantom stock units purchased by the trustee of the bank's rabbi trust under the Columbia Bank Stock Based Deferral Plan; those stock units will be settled in shares upon distribution. The transaction price is shown as $14.33 per share. The report also records a disposition of 8,048 shares and reflects 3,207 shares reported as indirect ownership from a stock award (Stock Award IV) that vests March 11, 2026. Following the reported activity, the filing lists 25,061.029 shares as beneficially owned. The form is signed by a power of attorney on 08/12/2025.

John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. (CLBK), reported changes in his beneficial ownership related to both stock awards and option holdings. On 08/08/2025 the Form 4 shows a disposition of 60,769 shares and an acquisition of phantom stock units purchased into the company's rabbi trust under the Columbia Bank Stock Based Deferral Plan that will be settled in shares on distribution.

The filing also details indirect holdings of common stock through retirement and benefit vehicles—17,130 shares via 401(k), 7,620 via ESOP, 7,051 via SERP, 4,214 via SIM—and multiple stock awards (13,781, 12,068, 11,723). Derivative holdings include 188,235 fully vested options (exercise $15.60, exp. 07/23/2029) and additional outstanding options totaling 41,190 with stated vesting schedules and later expirations.

Allyson Katz Schlesinger, SEVP & Head of Consumer Banking of Columbia Financial, Inc. (CLBK), filed a Form 4 reporting changes in her beneficial ownership with an earliest transaction date of 08/08/2025. The filing shows an acquisition of stock-based deferral units purchased through a rabbi trust under the Columbia Bank Stock Based Deferral Plan that will be settled in shares upon distribution. The Form also reports a disposition of 64,281 common shares and lists multiple indirect holdings: 6,683 (ESOP), 6,459 (SERP), 4,683 (SIM), and stock award balances of 14,470, 12,672, and 12,288 for Stock Award II, III and IV respectively. Reported direct option holdings include 155,294, 12,632, 9,292, and 21,289 stock options with stated exercise prices and vesting schedules noted in the filing. The Form is signed by a power of attorney on 08/12/2025.

Lucy Sorrentini, a director of Columbia Financial, Inc. (CLBK), reported changes in her beneficial ownership tied to company compensation plans. On 08/08/2025 she received 166.7537 phantom stock units purchased by the trustee of a rabbi trust under the Columbia Bank Stock Based Deferral Plan at a reported unit price of $14.33; those units are indirect holdings and will be settled in shares upon distribution. The filing also discloses a disposition of 11,664 common shares and indirect beneficial ownership of 3,207 shares from a stock award that vests on March 11, 2026. The Form 4 was filed by one reporting person and identifies Sorrentini as a director.

Columbia Financial director Noel R. Holland reported transactions on 08/08/2025. The filing shows an acquisition through the company's stock-based deferral plan (phantom stock purchased by a rabbi trust) and a separate disposal of 33,519 common shares. The table lists indirect holdings of 46,280 shares in a SEP-IRA and 3,207 shares attributed to a Stock Award IV.

The report also discloses 83,294 stock options outstanding that are exercisable through 07/23/2029 with an exercise price of $15.60. Stock Awards noted in the filing vest on 03/11/2026. The acquisition via the deferral plan is described as phantom stock units that will be settled in shares upon distribution. The form was signed by a power of attorney on 08/12/2025.